BlackRock Japan’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

BlackRock Japan’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,811	Closed	-$25K	–	1444
2016 Q3	$25K	Buy	+2,811	New	+$20K	﹤0.01%	1092
2016 Q1	–	Sell	-3,480	Closed	-$18K	–	1565
2015 Q4	$18K	Sell	3,480 -311	-8%	-$1.8K	﹤0.01%	1183
2015 Q3	$23K	Buy	3,791 +1,192	+46%	+$14.6K	﹤0.01%	1081
2015 Q2	$41K	Buy	+2,599	New	+$31.6K	﹤0.01%	1108
2014 Q2	–	Sell	-434	Closed	-$4K	–	1545
2014 Q1	$4K	Buy	+434	New	+$6.27K	﹤0.01%	1382

BlackRock Japan's RPTP Position: Q4 2016 in Review

BlackRock Japan sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 2,811 shares — an estimated $25K sold.

BlackRock Japan first reported a position in RPTP in Q1 2014 and held it in 5 quarters. The position peaked at $41K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

BlackRock Japan reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 2,811 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $25K.
BlackRock Japan first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2014 and held it in 5 quarters.
BlackRock Japan's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $41K in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.